Get Your Personalized Supplement StackSupplement Stack Quiz

Bifido Blend

Also known as: Bifidobacteria, probiotic blend, Bifidobacterium spp.

Overview

Bifidobacterium spp. are a group of probiotic bacteria commonly found in the human gut microbiota. They are often included in multi-strain probiotic formulations aimed at improving gut health. These bacteria are known for their role in maintaining gut barrier integrity, modulating the immune system, and producing short-chain fatty acids like butyrate. Research on Bifidobacterium, while extensive for probiotics in general, varies in quality and specificity depending on the strain and blend composition. Evidence suggests potential benefits in improving intestinal permeability and managing non-alcoholic fatty liver disease (NAFLD). Bifidobacteria are typically administered orally, often in enteric-coated capsules to enhance survival through the stomach acid. Effective colonization requires a sufficient dose, generally at least 10⁹ CFU.

Benefits

Bifidobacterium supplementation demonstrates several potential health benefits, particularly related to gut health and metabolic function. Meta-analyses suggest that Bifidobacterium can improve intestinal permeability by increasing transepithelial electrical resistance (TER) and reducing serum zonulin, endotoxin, and LPS levels. In individuals with NAFLD, Bifidobacterium supplementation has been shown to reduce liver enzymes (ALT and AST) and improve insulin resistance. However, the evidence for glucose control in humans is inconclusive, with some animal studies showing positive effects but human trials yielding mixed results. It's important to note that the benefits can be strain-specific, with certain strains like *B. infantis* 35624 exhibiting unique immunomodulatory effects.

How it works

Bifidobacterium exerts its beneficial effects through several mechanisms. Primarily, it strengthens the gut barrier by upregulating tight junction proteins such as occludin and ZO-1, which reduces intestinal permeability. It also modulates the LPS/TLR4/NF-κB pathway, reducing inflammation. Furthermore, Bifidobacterium contributes to the production of short-chain fatty acids (SCFAs), particularly butyrate, which serves as an energy source for colonocytes and has anti-inflammatory properties. The bioavailability and effectiveness of Bifidobacterium are strain-dependent, and a sufficient dose (≥10⁹ CFU) is required for colonization and to exert its beneficial effects.

Side effects

Bifidobacterium supplementation is generally considered safe, but some side effects have been reported. The most common side effects are mild gastrointestinal distress, such as bloating, gas, or abdominal discomfort, which occur in approximately 5-10% of users. In rare cases, particularly in immunocompromised patients or those with central venous catheters, bacteremia has been reported. There are no significant reported drug interactions, but caution is advised in individuals with severe immunosuppression. It is important to start with a low dose and gradually increase it to minimize potential gastrointestinal side effects. Individuals with underlying health conditions should consult with a healthcare professional before starting Bifidobacterium supplementation.

Dosage

The effective dosage range for Bifidobacterium is typically between 10⁹ and 10¹¹ CFU per day. For clinical outcomes, supplementation should be continued for 4 to 28 weeks. Enteric-coated capsules are often preferred to enhance survival through the acidic environment of the stomach. It is generally recommended to take Bifidobacterium with food to further improve gastric survival. While specific upper limits have not been definitively established, exceeding recommended dosages may increase the risk of gastrointestinal side effects. Dosages may vary depending on the specific strain and the intended health benefit.

FAQs

How long until results appear?

Improvements in gut barrier markers may be observed within 4 weeks, while metabolic effects may require 8–12 weeks of consistent supplementation. Individual responses can vary.

Should I take with food?

Yes, taking Bifidobacterium with food is recommended to enhance its survival through the stomach and improve its delivery to the intestines.

Are benefits strain-specific?

Yes, the benefits of Bifidobacterium can be strain-specific. For example, *B. infantis* 35624 has shown unique immunomodulatory effects compared to other strains.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/37168869/ – This meta-analysis of 26 RCTs (n=1,891) found that probiotics significantly improve intestinal permeability and reduce inflammation. The study highlights the potential of probiotics in enhancing gut barrier function, but also notes high heterogeneity among the included studies, suggesting that results should be interpreted with caution.
https://pubmed.ncbi.nlm.nih.gov/37923223/ – This meta-analysis examined the effects of Bifidobacterium on glucose control, combining data from 6 human RCTs and 16 animal studies. The findings suggest species-specific effects, with inconclusive results from human data contrasting with strong positive results in animal models, indicating a need for further, well-powered human trials.
https://onlinelibrary.wiley.com/doi/10.1155/2019/1484598 – This meta-analysis of 28 trials (n=1,555) investigated the impact of probiotics on NAFLD. The results indicate that probiotics can reduce liver enzymes and improve insulin resistance in patients with NAFLD. However, the study acknowledges the short duration of the included trials (≤6 months), suggesting that long-term effects require further investigation.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2018.00124/full – This article discusses the immunomodulatory effects of *B. infantis* 35624. It highlights the strain's ability to modulate the immune system, suggesting its potential use in managing inflammatory conditions. The research emphasizes the importance of strain specificity when considering the benefits of probiotic supplementation.